major depressive disorder. Mood disorder due to known physiological condition with major depressive-like episode
Conditions
Interventions
Intervention 1: Intervention group: One capsule daily (each capsule containing about 500 mg of extract) for 8 weeks. Intervention 2: Control group:They receive one 500 mg capsules of placebo daily fo
Sponsors
Kerman University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to 55 Years
Inclusion criteria
Inclusion criteria: Outpatient with Major Depression Based on DSM-5 Criterion, 18-55 years old, depressed patient who has never been on medication and is a candidate for SSRI treatment.
Exclusion criteria
Exclusion criteria: Pregnancy, lactation, having underlying medical or psychiatric illnesses, hypersensitivity reactions to rosemary, people at high risk of suicide, mental retardation - dependence on a variety of substances
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Anxiety. Timepoint: At the beginning of the study and ,the fourth and eight weeks after the beginning of the study. Method of measurement: Hospital Anxiety Depression Scale (anxiety sub-scale).;Depression. Timepoint: At the beginning of the study and ,the fourth and eight weeks after the beginning of the study. Method of measurement: Beck Depression Inventory second edition. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactFatemeh Dabaghzadeh
Kerman University of Medical Sciences
Outcome results
None listed